Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Dec. 31, 2021
Mar. 04, 2022
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2021  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 001-37348  
Entity Registrant Name Corbus Pharmaceuticals Holdings, Inc.  
Entity Central Index Key 0001595097  
Entity Tax Identification Number 46-4348039  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 500 River Ridge Drive  
Entity Address, City or Town Norwood  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02062  
City Area Code 617  
Local Phone Number 963-0100  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol CRBP  
Security Exchange Name NASDAQ  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Public Float $ 201,863,338  
Entity Common Stock, Shares Outstanding   125,243,381
ICFR Auditor Attestation Flag false  
Documents Incorporated by Reference

Portions of the registrant’s proxy statement for the 2022 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after the registrant’s fiscal year ended December 31, 2021, are incorporated by reference in Part III of this Form 10-K.

Auditor Firm ID 274  
Auditor Location Philadelphia, Pennsylvania